Sunday, March 14, 2010

Immunologic Pharmacopeia Index

Adverse Effects: Adverse events after immunization: Reports and results. Hosp Pharm 1995;30(Nov):1031-2,1035-6,1038,1041.

Advocacy of Vaccines: Are vaccines expiring in your refrigerator? Become an advocate! Hosp Pharm 1996;31(Sep):1075-6,1081-8.

Allergen Extracts: Allergen-extract compounding by pharmacists. Hosp Pharm 1992;27(Feb):145,149-53,165.

Allergen Patch Tests: Allergen patches: Testing for contact dermatitis. Hosp Pharm 1996;31(Apr):419-20,423-5,429.

Anaphylaxis & Epinephrine: Anaphylaxis: Epinephrine and emergency responses. Hosp Pharm 1997;32(Oct):1377-8,1382-4,1387-9.

Antibodies: Borrowed antibodies: Comparing and contrasting immune globulins. Hosp Pharm 2000;35(Apr):393-404.

Antilymphocyte Antibodies: Isoantibodies: II. Comparison of antilymphocyte antibodies. Hosp Pharm 1993;28(Jan):42,45-9.

Antitoxins: Immunoantidotes: II. One hundred years of antitoxins. Hosp Pharm 1992;27(Jul):637-40,645-6,664.

Antivenins: Immunoantidotes: I. Antivenins. Hosp Pharm 1992;27(May):427-31,435,449.

Bibliography, Annotated: Resources for immunologic advocacy: An annotated bibliography. Hosp Pharm 1998;33(Mar):323-4,327-30,332-3.

Biological Terrorism: The pharmacist's response to biological or chemical terrorism: Developing a preparedness plan. Hosp Pharm 1998;33(Nov):1423-4,1427-8,1430-1.

Children: How to explain vaccines to children and other inquisitive people. Hosp Pharm 1999;34(Dec):1421-6,1429-32,1435-7.

Communication: Interviewing and counseling patients about immunizations. Hosp Pharm 1991;26(Nov):1006-10.

Delayed Hypersensitivity: Delayed-hypersensitivity testing: Guide to product selection. Hosp Pharm 1990;25(Dec):1102-4,1106-7.

Dextrans: Dextran-1: An antibody antagonist. Hosp Pharm 1993;28(Feb):140-4.

Digoxin Antibodies: Immunoantidotes: III. Antidigoxin, antichemical, and other immunoantidotes. Hosp Pharm 1992;27(Sep):786,789-91,795-6.

Diluents & Excipients: Immunologic necessities: Diluents, adjuvants, and excipients. Hosp Pharm 1996;31(Nov):1387-8,1390,1392,1397-8,1401.

Disease Prevention: Prevent all the disease you can, then treat the rest: Promoters of public health. Hosp Pharm 1996;31(Jun):691-4,699-700,703-4.

Documentation: Get it in writing: Documenting immunizations. Hosp Pharm 1991;26(Oct):901-4.

Errors with Vaccines: Recognizing and preventing errors with immunologic drugs. Hosp Pharm 1996;31(Jul):791-4,799,803-4.

Ethnicity: Overcoming immunization disparities based on race and ethnicity. Hosp Pharm 1999;34(May):550,553-6,559.

Guillain-Barré syndrome and vaccination: Usually unrelated. Hosp Pharm 2001;36(Feb):199-200,202-4,206-7.
ARTICLE

Haemophilus influenzae: How do the Haemophilus vaccines vary? Hosp Pharm 1992;27(Jan):41-5,48-9.

Health-System Pharmacy-I: Immunizations: What's a health-system pharmacy to do? (Part 1). Hosp Pharm 1998;33(Jun):742,745-750,753.

Health-System Pharmacy-II: Immunizations: What's a health-system pharmacy to do? (Part 2). Hosp Pharm 1998;33(Jul):870-2,876-80.

Hepatitis A: Hepatitis A: Immunization against the "other" hepatitis. Hosp Pharm 1996;31(Mar):280,283, 287-90,293.

Hepatitis B: Are the hepatitis B vaccines different? Hosp Pharm 1990;25(Aug):757-9,771.

History, 1920 to 1959: Milestones in immunologic history: 1920 to 1959. Hosp Pharm 1994;29(Jun):621-2,625-6,629-31.

History, 1960 to 1994: Milestones in immunologic history: 1960 to 1994. Hosp Pharm 1994;29(Jul):712-6,719-20.

History, Antiquity to 1919: Milestones in immunologic history: Antiquity to 1919. Hosp Pharm 1994;29(May):477-8,480-3.

Hymenoptera Venoms: Immunotherapy for Hymenoptera insects: Bees, wasps, hornets, and fire ants. Hosp Pharm 1992;27(Oct):883,887-90,905.

Hypersensitivities, Vaccine: Clinical management of hypersensitivities to vaccine components. Hosp Pharm 1997;32(Jan):77-8,81-4,87.

Immunization Policies: American immunization policies: Actions speak louder than words. Hosp Pharm 1993;28(Dec):1233-4,1237-40.

ImmunoFacts, Making of: The making of ImmunoFacts: How a reference book was built. Hosp Pharm 1993;28(Aug):783-6,788-90.

Implications for Pharmacists: The immunologic pharmacopeia: Implications for the pharmacist. Hosp Pharm 1996;31(Oct):1240-1,1245-6,1253-4.

Influenza: Influenza vaccine: October is the month for action. Hosp Pharm 1991;26(Sep):810-2,814-5.

Injection Technique: Injection technique and procedures: Mind over method. Hosp Pharm 1997;32(May):652,657-8,661-2,664.

Injury Compensation: Compensation for vaccine injury: Balancing society's need and personal risk. Hosp Pharm 1995;30(Sep):831-2,834-6.

International Vaccines: International review of immunologic drugs. Hosp Pharm 1997;32(Feb):215-6,219-20,223-4.

Legal & Liability Issues: Legal and liability issues related to immunizations. Hosp Pharm 1998;33(Jan):97-8,101-5,115.

Lyme disease vaccine, focusing on dosing and adverse events. Hosp Pharm 2001;36(Aug):857-8,860-1,864-6.

Manufacturing Industry: The biologics industry: How federal regulation enhances quality of vaccine and antibody manufacture. Hosp Pharm 2000;35(Oct):1079-89.

Measles: Pharmacists in the continuing fight against measles. Hosp Pharm 1991;26(Feb):133-5,140,142.

Meningococcal Disease: Meningococcal vaccine: Outbreaks, travel, and more. Hosp Pharm 1997;32(Sep):1219-1223,1306.

Meningococcal Vaccines: Expanding protection from infants to college. Hosp Pharm 2001;36(Oct):1078,1082-3,1086-8,1090.

Millennium: Immunization from the perspective of a millennium. Hosp Pharm 2000;35(Jun):619-30.

Miscellany: A miscellany of obscure vaccines: Adenovirus, anthrax, mixed bacteria, and Staphylococcus. Hosp Pharm 1993;28(Mar):259-61,264-6.

Misconceptions: Vaccine misconceptions and inappropriate contraindications lead to preventable illness and death. Hosp Pharm 1998;33(Dec):in press.

Mumps: Mumps vaccine: Protect adults as well as children. Hosp Pharm 1991;26(May):452-5.

Natural History of Vaccines: The natural history of a vaccine and its disease. Hosp Pharm 1996;31(May):559,563-4,567-8,571-2.

Nursing Homes & Vaccines: Immunizations in nursing facilities: Roles for consultant pharmacists. Hosp Pharm 1998;33(Oct):1182,1187-94.

Obsolete-I: Obsolete immunologic drugs, Part I. Hosp Pharm 1997;32(Mar):348-350,353-4,357-8.

Obsolete-II: Obsolete immunologic drugs, Part II. Hosp Pharm 1997;32(Apr):492,501-3,507--8,511.

Pandemic influenza: Planning now to avoid another tragedy. Hosp Pharm 1999;34(Jul):845-6,849-51,855-6.

Penicillin Allergy: Predicting allergy to penicillin: A decision-maker's dilemma. Hosp Pharm 1993;28(Oct):1020-5.

Pertussis-I: Pertussis (Part 1): A preventable threat, despite controversy. Hosp Pharm 1997;32(Jul):1002,1005-8,1011-2.

Pertussis-II: Pertussis (Part 2): Advantages of acellular vaccines. Hosp Pharm 1997;32(Aug):1115-8,1121-2,1125.

Pharmacoimmunology 101: Pharmacoimmunology 101: Antigens, antibodies, cells, et cetera. Hosp Pharm 1993;28(May):413-6,419.

Pharmacoimmunology 102: Pharmacoimmunology 102: Comparisons and contrasts. Hosp Pharm 1993;28(Jun):544-6,548,560.

Pharmacoimmunology 103: Pharmacoimmunology 103: Differential pharmaceutics and utilization. Hosp Pharm 1993;28(Jul):688-91,694,697.

Pneumococcal Disease: Pneumococcal pneumonia: Don't wait, vaccinate. Hosp Pharm 1990;25(Sep):866-9; letter response 1991;26(Mar):270-1.

Policy-making: How the Advisory Committee on Immunization Practices reached recent decisions. Hosp Pharm 2000;35(Feb):165-76.

Poliovirus: Poliovirus: Which vaccine when? Hosp Pharm 1997;32(Jun):866,869-72,875-6,880.

Pregnancy: Vaccines and antibodies in relation to pregnancy and lactation. Hosp Pharm 1999;34(Sep):949-52,955-6,959-60.

Rabies: Rabies: America's only overused immunization. Hosp Pharm 1995;30(Apr):323-8, errata 894.

Research-"Uncommon:" The research pipeline: III. Investigational vaccines for "uncommon" diseases. Hosp Pharm 1994;29(Mar):282-8.

Research-Common: The research pipeline: I. Investigational vaccines for "common" diseases. Hosp Pharm 1994;29(Jan):64-7,71.

Research-HIV: The research pipeline: II. Vaccines and antibodies against the human immunodeficiency virus. Hosp Pharm 1994;29(Feb):142-7.

Research-Immunoglobulins: The research pipeline: IV. Investigational immune globulins. Hosp Pharm 1994;29(Apr):384-7,394.

Rho(D) Immune Globulin: Isoantibodies: I. Antierythrocytic Rho(D) immune globulin. Hosp Pharm 1992;27(Nov):981-2,985-7.

Risk Communication: Are vaccines safe? Risk communication applied to vaccines. Hosp Pharm 1999;34(Jun):713-4,717-8,721-23,727-9.

Rotavirus: Rotavirus: Leading cause of pediatric gastroenteritis. Hosp Pharm 1997;32(Nov):1480,1484-6,1489.

Rubella: Preventing rubella and congenital rubella syndrome. Hosp Pharm 1991;26(Jun):553-5,558,574.

Safety: The individual perspective: Did this vaccine harm this person? Hosp Pharm 2001;36(Apr):413-418,420,464.

Sake of Others: Being immunized for the sake of others. Hosp Pharm 1999;34(Jan):in press.

Schedules: How to interpret immunization schedules and records. Hosp Pharm 1999;34(Apr):482-6,489-91.

Side effects of vaccination: A consumer's guide to cause and effect. Hosp Pharm 2000;35(Dec):1308-18.

Standards: High expectations: Standards and guidelines for immunization delivery. Hosp Pharm 2000;35(Aug):841-51.

Storage & Handling: Storing, handling, and shipping immunologic drugs. Hosp Pharm 1996;31(Aug):936-8,943-4,947-8.

Targeting vaccines to specific clusters of people. Hosp Pharm 1999;34(Feb):238-45.

Tetanus Toxoid: Stop buying tetanus toxoid (with one exception). Hosp Pharm 1990;25(Apr):361-2.

The Individual Perspective: Did This Vaccine Harm This Person? Hosp Pharm 2001:36(April):413-420, 464.
ARTICLE

Transplantation: Immunization in relation to organ transplantation. Hosp Pharm 1999;34(Mar):339-41,345-6,349-51.

Transplants & Vaccines: Immunization in relation to organ transplantation. Hosp Pharm 1999;34(Mar):in press.

Travel-I: Immunizations for international travel, Part I. Hosp Pharm 1991;26(Jul):636-7,640-1,657.

Travel-II: Immunizations for international travel, Part II. Hosp Pharm 1991;26(Aug):722-5,738.

Tuberculosis, BCG: Tuberculosis and the pharmacist: Rational use of tuberculins and BCG. Hosp Pharm 1990;25(Jul):673-7.

Vaccine Identification Standards Initiative (VISI): Towards clearer labels and common nomenclature. Hosp Pharm 2002;37(Jan):58,60,62-64,67-68,71-72,74.

Vaccine Information Statements: The importance of up-to-date Vaccine Information Statements. Hosp Pharm 1999;34(Sep):1072-3,1076-8,1081-2,1085-7.

Vaccines for Workers: Immune Aspects of Occupational Health. Hosp Pharm 2001;36(May):534-546.
ARTICLE

Varicella: Varicella: More than just chickenpox. Hosp Pharm 1996;31(Feb):169-70,173-4,176-7,188.

Veterinary-I: Veterinary vaccines: I. Introduction and companion animals. Hosp Pharm 1994;29(Dec):1108-10,1113-4,1118-9.

Veterinary-II: Veterinary vaccines: II. Horses, livestock, and other animals. Hosp Pharm 1995;30(Mar):222-8,235.

Workers: Vaccines for workers: Immune aspects of occupational health. Hosp Pharm 2001;36(Jun):534,537-8,541-4,546.